HEATHER YOUNG: Open Payments
NPI 1003480716 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 79 payments from 14 companies in 2025. Trend: 2023 $530 · 2024 $1,889 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $357 |
| Madrigal Pharmaceuticals | 12 | $281 |
| Gilead Sciences, Inc. | 7 | $175 |
| Aimmune Therapeutics, Inc. | 6 | $121 |
| Phathom Pharmaceuticals, Inc. | 8 | $96 |
| GENZYME CORPORATION | 3 | $82 |
| QOL Medical, LLC | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Lilly USA, LLC | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $56 |
Products named: REZDIFFRA, RINVOQ, VRAYLAR, Livdelzi, DUPIXENT, VOQUEZNA, Sucraid, VOWST.
Industry payments across AL — which companies pay providers there.
